Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Pyxis Oncology Inc fell by 169.63m. Cash Flow from Financing totalled 5.93m or -- of revenues. In addition the company used 70.71m for operations while cash used for investing totalled 104.85m.
Cash flow per share | -0.9998 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 2.59 |
---|---|
Tangible book value per share | 2.19 |
More ▼
Balance sheet in USDView more
Current ratio | 7.33 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0008 |
---|---|
Total debt/total capital | 0.0008 |
More ▼